Literature DB >> 14662633

Coaching patients On Achieving Cardiovascular Health (COACH): a multicenter randomized trial in patients with coronary heart disease.

Margarite J Vale1, Michael V Jelinek, James D Best, Anthony M Dart, Leeanne E Grigg, David L Hare, Betty P Ho, Robert W Newman, John J McNeil.   

Abstract

BACKGROUND: Disease management programs in which drugs are prescribed by dietitians or nurses have been shown to improve the coronary risk factor profile in patients with coronary heart disease. However, those disease management programs in which drugs are not prescribed by allied health professionals have not improved coronary risk factor status. The objective of the Coaching patients On Achieving Cardiovascular Health (COACH) study was to determine whether dietitians or nurses who did not prescribe medications could coach patients with coronary heart disease to work with their physicians to achieve the target levels for their total cholesterol (TC) and other risk factors.
METHODS: Multicenter randomized controlled trial in which 792 patients from 6 university teaching hospitals underwent a stratified randomization by cardiac diagnosis within each hospital: 398 were assigned to usual care plus The COACH Program and 394 to usual care alone. Patients in The COACH Program group received regular personal coaching via telephone and mailings to achieve the target levels for their particular coronary risk factors. There was one coach per hospital. The primary outcome was the change in TC (DeltaTC) from baseline (in hospital) to 6 months after randomization. Secondary outcomes included measurement of a wide range of physical, nutritional, and psychological factors. The analysis was performed by intention to treat.
RESULTS: The COACH Program achieved a significantly greater DeltaTC than usual care alone: the mean DeltaTC was 21 mg/dL (0.54 mmol/L) (95% confidence interval [CI], 16-25 mg/dL [0.42-0.65 mmol/L]) in The COACH Program vs 7 mg/dL (0.18 mmol/L) (95% CI, 3-11 mg/dL [0.07-0.29 mmol/L]) in the usual care group (P<.0001). Thus, the reduction in TC from baseline to 6 months after randomization was 14 mg/dL (0.36 mmol/L) (95% CI, 8-20 mg/dL [0.20-0.52 mmol/L]) greater in The COACH Program group than in the usual care group. Coaching produced substantial improvements in most of the other coronary risk factors and in patient quality of life.
CONCLUSIONS: Coaching, delivered as The COACH Program, is a highly effective strategy in reducing TC and many other coronary risk factors in patients with coronary heart disease. Coaching has potential effectiveness in the whole area of chronic disease management.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14662633     DOI: 10.1001/archinte.163.22.2775

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  79 in total

1.  Impact of a lifestyle modification program on the metabolic syndrome and associated risk factors in long-term survivors of stem cell transplantation.

Authors:  E Viner Smith; A C Tierney; D Klarica; P Walker; S Avery
Journal:  Bone Marrow Transplant       Date:  2015-12-21       Impact factor: 5.483

2.  Using conjoint analysis to model the preferences of different patient segments for attributes of patient-centered care.

Authors:  Charles E Cunningham; Ken Deal; Heather Rimas; Heather Campbell; Ann Russell; Jennifer Henderson; Anne Matheson; Blake Melnick
Journal:  Patient       Date:  2008-12-01       Impact factor: 3.883

Review 3.  Behavior matters.

Authors:  Edwin B Fisher; Marian L Fitzgibbon; Russell E Glasgow; Debra Haire-Joshu; Laura L Hayman; Robert M Kaplan; Marilyn S Nanney; Judith K Ockene
Journal:  Am J Prev Med       Date:  2011-05       Impact factor: 5.043

4.  When it comes to lifestyle recommendations, more is sometimes less: a meta-analysis of theoretical assumptions underlying the effectiveness of interventions promoting multiple behavior domain change.

Authors:  Kristina Wilson; Ibrahim Senay; Marta Durantini; Flor Sánchez; Michael Hennessy; Bonnie Spring; Dolores Albarracín
Journal:  Psychol Bull       Date:  2014-12-22       Impact factor: 17.737

5.  A multidimensional integrative medicine intervention to improve cardiovascular risk.

Authors:  David Edelman; Eugene Z Oddone; Richard S Liebowitz; William S Yancy; Maren K Olsen; Amy S Jeffreys; Samuel D Moon; Amy C Harris; Linda L Smith; Ruth E Quillian-Wolever; Tracy W Gaudet
Journal:  J Gen Intern Med       Date:  2006-07       Impact factor: 5.128

6.  Feasibility, effectiveness and cost-effectiveness of a telephone-based weight loss program delivered via a hospital outpatient setting.

Authors:  M E Whelan; A D Goode; E G Eakin; J L Veerman; E A H Winkler; I J Hickman; M M Reeves
Journal:  Transl Behav Med       Date:  2016-09       Impact factor: 3.046

Review 7.  Interventions to enhance adherence to dietary advice for preventing and managing chronic diseases in adults.

Authors:  Sophie Desroches; Annie Lapointe; Stéphane Ratté; Karine Gravel; France Légaré; Stéphane Turcotte
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28

8.  A population-based lifestyle intervention to promote healthy weight and physical activity in people with cardiac disease: the PANACHE (Physical Activity, Nutrition And Cardiac HEalth) study protocol.

Authors:  Janice Sangster; Susan Furber; Margaret Allman-Farinelli; Marion Haas; Philayrath Phongsavan; Andy Mark; Adrian Bauman
Journal:  BMC Cardiovasc Disord       Date:  2010-04-08       Impact factor: 2.298

9.  Implementation and success of nurse telephone counseling in linguistically isolated Korean American patients with high blood pressure.

Authors:  Hae-Ra Han; Jiyun Kim; Kim B Kim; Seonghee Jeong; David Levine; Chunyu Li; Heejung Song; Miyong T Kim
Journal:  Patient Educ Couns       Date:  2009-11-30

10.  The effectiveness of physical activity monitoring and distance counselling in an occupational health setting--a research protocol for a randomised controlled trial (CoAct).

Authors:  Karita Reijonsaari; Aki Vehtari; Willem van Mechelen; Timo Aro; Simo Taimela
Journal:  BMC Public Health       Date:  2009-12-31       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.